Dewpoint Therapeutics
Dewpoint Therapeutics is a biotech company developing a drug platform that targets biomolecular condensates. Its technology uses machine-learning-based image analysis tools for visualizing condensates and offers an engine for genetically linked condensatopathy which is a collection of engineered cell lines with trackable condensates to prevent harmful protein sequestration, helping healthcare providers to have access to new therapies to address unmet needs. The company was founded in 2018 and is headquartered in Boston, Massachusetts.
Domain
dewpointx.com
Country
United StatesIndustry
BiotechnologyEmployees
51-100
Last Funding
$3.4M
Founded
2017
Tech Stack (18 technologies)
Frequently Asked Questions
What technologies does Dewpoint Therapeutics use?+
Dewpoint Therapeutics uses 18 technologies including Google Analytics, Google Tag Manager, Swiper.
What industry is Dewpoint Therapeutics in?+
Dewpoint Therapeutics operates in the Biotechnology industry.
Where is Dewpoint Therapeutics based?+
Dewpoint Therapeutics is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026